peptidefix

Peptides / Sermorelin / Australia

Sermorelin in Australia

Legal status, what it is, and the listed suppliers in Australia that list it.

Legal status in Australia

Prescription only. Listed in Schedule 4 of the Poisons Standard (June 2026).

As understood at 2026-09-22. Verify with the TGA.

What Sermorelin is

Sermorelin is the first 29 amino acids of growth hormone-releasing hormone, the shortest fragment that still triggers the pituitary to release growth hormone. It was developed as a medicine for growth hormone deficiency in children and marketed under the name Geref; there is no current FDA label for it. In Australia it is a prescription-only substance.

Full Sermorelin page: targets and research →

Listed suppliers in Australia

3 of the 10 suppliers we list in Australia list Sermorelin. Listed, not endorsed: each row is the supplier’s own stated terms.

Au Peptide Labs Australia For laboratory research use only. Not for human consumption. Aussie Peptides Australia Research use only. Statements have not been evaluated by the TGA. We do not ship internationally at this time. Synapse Peptides Australia Australia All products are supplied strictly for research purposes only and are not intended for human or veterinary use.

Clinical Research

Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone
Neyzi O, Yordam N, Ocal G, et al. (1993). Acta Paediatrica. human 43 prepubertal children aged 4 to 19 with growth hormone deficiency of hypothalamic origin, randomised to three treatment groups for 6 months
Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration
Wilton P, Chardet Y, Danielson K, et al. (1993). Acta Paediatrica. human 30 healthy men aged 19 to 43, intravenous and intranasal administration
Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth
Hummelink R, Sippell WG, Benoit KG, et al. (1993). Acta Paediatrica. human 8 short prepubertal children with growth hormone deficiency, 6-month intranasal pilot study
Effects of long-term growth hormone releasing hormone 1-29 in significantly short children
Grunt JA, Schwartz ID, Buchanan C, Howard CP (1995). Acta Paediatrica. human 7 children with idiopathic short stature and normal growth hormone levels, treated up to 24 months